Answers are grounded in this paper and cite their sources.
The relative safety and efficacy of early steroid withdrawal in kidney transplant patients after basiliximab compared to anti-thymocyte globulin (ATG) induction therapy is unknown. We aimed to compare kidney allograft outcomes in steroid use versus steroid discontinuation after basiliximab and ATG induction from the United Network for Organ Sharing (UNOS) database.
No takes yet. Share an insight, caveat, or question.
Nissaisorakarn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: